Navigation Links
Puritan Awarded New Canadian Patent for PurFlock® Ultra Flocked Swab

Guilford, ME (PRWEB) July 09, 2013

Puritan Medical Products, a leading manufacturer of flocked swabs, announced today that it has been granted a new Canadian patent for its high-performance PurFlock® Ultra flocked swab.

The latest Canadian patent (No. 2744678) is the sixth specimen collection device patent that Puritan has been awarded worldwide.

“The Canadian patents for our flocked swabs are a testament to Puritan's celebrated innovation in the single-use specimen collection microbiology transport market," said Puritan EVP of Global Sales Timothy Templet. “With our sixth patent, Puritan continues to expand our position as a global leader in the invention and manufacture of high-performance flocked swabs for specimen collection and transport.”

By combining a unique microstructure with cutting-edge fibers, Puritan’s PurFlock® Ultra and HydraFlock® swabs provide superior sample collection, rapid elution, and increased test sensitivity. Both flocked swabs are used in bacterial and viral transport systems and have been globally validated with automated systems and manual laboratory testing practices.

A Canadian device and method patent (No. 2744282) has been previously awarded for the HydraFlock® swab. Puritan has also received U.S. patents for the HydraFlock® swab (No. 8334134) and the PurFlock® Ultra (No. 8420385). In June, Puritan received two European patents for the PurFlock® Ultra (No. 2263549) and HydraFlock® flocked swabs (No. 2263548).

Puritan has expanded rapidly over the last few years as a direct result of the company’s effort to meet the evolving needs of the microbiology, healthcare, forensic, critical environment, food safety, and drug manufacturing industries.

Today, Puritan manufactures more than 35 types of specimen collection devices including the newly patented flocked swabs or media-filled transport systems. Puritan’s on-site state-of-the-art microbiology laboratory conforms to stringent U.S. quality system regulations. All research and development, product testing, approval and release take place at Puritan's facility in Guilford, ME.

About Puritan
Puritan Medical Products Co, LLC is North America’s largest manufacturer of single-use medical and diagnostics products. All products are manufactured at their Guilford, ME, U.S. facility, which includes custom media manufacturing and compounding capability to meet a multitude of customer needs.

Media Contact
Timothy Templet
Puritan Medical Products

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
2. Puritan Medical Products Launches New Series to Tell Customer Stories
3. K computer research results awarded ACM Gordon Bell Prize
4. BioPower Systems Awarded $5 Million from Victorian Government
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
9. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
10. Sloan Research Fellowships Awarded to 126 Young Scholars
11. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Post Your Comments:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
Breaking Biology News(10 mins):